A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Clinical trial NCT04447287 · COMPLETED
Trial details
- NCT number
- NCT04447287
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2020-11-25
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.